Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Total Debt (2021 - 2024)

Biofrontera has reported Total Debt over the past 4 years, most recently at $296000.0 for Q2 2024.

  • Quarterly results put Total Debt at $296000.0 for Q2 2024, changed N/A from a year ago — trailing twelve months through Jun 2024 was $296000.0 (changed N/A YoY), and the annual figure for FY2023 was $3.9 million, down 43.76%.
  • Total Debt for Q2 2024 was $296000.0 at Biofrontera, down from $2.4 million in the prior quarter.
  • Over the last five years, Total Debt for BFRIW hit a ceiling of $7.2 million in Q3 2023 and a floor of $296000.0 in Q2 2024.
  • Median Total Debt over the past 4 years was $3.6 million (2021), compared with a mean of $4.3 million.
  • Biggest five-year swings in Total Debt: soared 122.42% in 2023 and later tumbled 66.51% in 2024.
  • Biofrontera's Total Debt stood at $3.2 million in 2021, then skyrocketed by 114.13% to $6.9 million in 2022, then crashed by 43.76% to $3.9 million in 2023, then crashed by 92.42% to $296000.0 in 2024.
  • The last three reported values for Total Debt were $296000.0 (Q2 2024), $2.4 million (Q1 2024), and $3.9 million (Q4 2023) per Business Quant data.